Sensome, the pioneer of microsensing technology for real-time, in situ tissue analysis, today announced the publication of a ...

A doctor has urged patients to proceed with caution when using cannabis during cancer immunotherapy and called for more ...

Using a novel method to analyze tumor growth rates, researchers at Fox Chase Cancer Center have provided the most in-depth ...

Cabometyx® is the first and only systemic therapy to be approved in the European Union for previously treated unresectable or ...

These findings highlight the dual roles of antioxidants in cancer. Their impact depends on cancer type, stage, and genetic alterations. In tumors where redox-sensitive signaling promotes cell death, ...

Scientists use patient-derived breast cancer organoids—or 3D mini-tumors—to study processes involved in slowing or stopping ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

This comprehensive review highlights the compositional and functional heterogeneity of intratumoral microbiota within the ...

Using a novel method to analyze tumor growth rates, researchers at Fox Chase Cancer Center have provided the most in-depth ...

Data from the KEYNOTE-B61 trial show tumor shrinkage in different types of kidney cancer, including papillary and chromophobe ...

Volume 17, Issue 6, on June 5, 2025, titled “Senescence caused by telomerase inactivation in myeloid, mesenchymal, and endothelial cells has distinct effects on cancer progression.” ...

Using a novel method to analyze tumor growth rates, researchers at Fox Chase Cancer Center have provided the most in-depth assessment to date of how fast breast cancers grow in patients and how ...